These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29327370)

  • 1. Role of immune system in tumor progression and carcinogenesis.
    Upadhyay S; Sharma N; Gupta KB; Dhiman M
    J Cell Biochem; 2018 Jul; 119(7):5028-5042. PubMed ID: 29327370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the immune system to treat cancer.
    Bhardwaj N
    J Clin Invest; 2007 May; 117(5):1130-6. PubMed ID: 17476342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise protects from cancer through regulation of immune function and inflammation.
    Hojman P
    Biochem Soc Trans; 2017 Aug; 45(4):905-11. PubMed ID: 28673937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quid pro Quo: A Tumor is Not Alone.
    Sacristán C; Tuveson DA
    Trends Mol Med; 2017 May; 23(5):375-376. PubMed ID: 28408271
    [No Abstract]   [Full Text] [Related]  

  • 6. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
    Fleming C; Morrissey S; Cai Y; Yan J
    Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cell recruitment and cell-based system for cancer therapy.
    Gao JQ; Okada N; Mayumi T; Nakagawa S
    Pharm Res; 2008 Apr; 25(4):752-68. PubMed ID: 17891483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.
    Payne KK; Bear HD; Manjili MH
    Future Oncol; 2014 Aug; 10(10):1779-94. PubMed ID: 25303057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting cytokines in adoptive T-cell therapy of cancer.
    Petrozziello E; Sturmheit T; Mondino A
    Immunotherapy; 2015; 7(5):573-84. PubMed ID: 26065481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of tumor-derived supernatants (TDS) on cancer cell progression: A review and update on carcinogenesis and immunotherapy.
    Ahmadpour S; Habibi MA; Ghazi FS; Molazadeh M; Pashaie MR; Mohammadpour Y
    Cancer Treat Res Commun; 2024; 40():100823. PubMed ID: 38875884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cancer stem cells, chemokines and their receptors in carcinogenesis, recurrences and metastatic spread of tumors].
    Raskin GA; Orlova RV; Protasova AÉ; Petrov SV; Ivanova AK; Pozharisskiĭ KM
    Vopr Onkol; 2013; 59(6):694-700. PubMed ID: 24624776
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
    Stewart TJ; Smyth MJ
    Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
    Nelson MH; Diven MA; Huff LW; Paulos CM
    J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunoediting from immune surveillance to immune escape.
    Kim R; Emi M; Tanabe K
    Immunology; 2007 May; 121(1):1-14. PubMed ID: 17386080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
    Vinay DS; Ryan EP; Pawelec G; Talib WH; Stagg J; Elkord E; Lichtor T; Decker WK; Whelan RL; Kumara HMCS; Signori E; Honoki K; Georgakilas AG; Amin A; Helferich WG; Boosani CS; Guha G; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Keith WN; Bilsland A; Bhakta D; Halicka D; Fujii H; Aquilano K; Ashraf SS; Nowsheen S; Yang X; Choi BK; Kwon BS
    Semin Cancer Biol; 2015 Dec; 35 Suppl():S185-S198. PubMed ID: 25818339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation.
    Trivanović D; Krstić J; Djordjević IO; Mojsilović S; Santibanez JF; Bugarski D; Jauković A
    Mediators Inflamm; 2016; 2016():7314016. PubMed ID: 27630452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Suppressor cells - the basis of the immunopathogenesis of cancer].
    Kozlov VA
    Vopr Onkol; 2016; 62(3):390-6. PubMed ID: 30462899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
    Vidya MK; Kumar VG; Sejian V; Bagath M; Krishnan G; Bhatta R
    Int Rev Immunol; 2018 Jan; 37(1):20-36. PubMed ID: 29028369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review.
    Chen VE; Greenberger BA; Taylor JM; Edelman MJ; Lu B
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):38-45. PubMed ID: 32251756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.